Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering Medroxyprogesterone Acetate.

Client Email

Product

Medroxyprogesterone Acetate
CAS 71-58-9
CAS 302-23-8
Megestrol Acetate
HEALTH CANADA PATENTS

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Coral Medroxyprogesterone Acetate

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Medroxyprogesterone Acetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 18 USDMF, 6 CEP/COS, 1 JDMF, 5 KDMF, 16 NDC API, 18 Listed Suppliers, $ API Reference Price

31 API Suppliers
18 USDMF
6 CEP/COS
1 JDMF
5 KDMF
16 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

4 API Suppliers

4 API Suppliers

FINISHED DOSAGE FORMULATIONS

153 FDF Dossiers, 41 FDA Orange Book, 48 Europe, 14 Canada, 22 Australia, 17 South Africa, 11 Listed Dossiers

153 FDF Dossiers
41 FDA Orange Book
48 Europe
14 Canada
22 Australia
17 South Africa
11 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG, TABLET;ORAL - 5MG, INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/ML, INJECTABLE;INJECTION - 150MG/ML

TABLET;ORAL - 10MG
TABLET;ORAL - 2.5MG
TABLET;ORAL - 5MG
INJECTABLE;INJECTION - 100MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INJECTION - 400MG/ML
INJECTABLE;INJECTION - 150MG/ML

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 SPI Pharma, 2 Seqens, 3 DKSH, 1 Jai Radhe Sales, 1 Boai NKY Pharmaceuticals Ltd, 11 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 27 BASF, 1 Clariant, 3 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 10 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 20 Kerry, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 15 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

59 Fillers, Diluents & Binders, 30 Direct Compression, 28 Coating Systems & Additives, 26 Solubilizers, 23 Controlled & Modified Release, 22 Thickeners and Stabilizers, 19 Lubricants & Glidants, 18 Granulation, 17 Parenteral, 16 Topical, 16 Co-Processed Excipients, 11 Disintegrants & Superdisintegrants, 11 Film Formers & Plasticizers, 11 Taste Masking, 5 Emulsifying Agents, 5 Chewable & Orodispersible Aids, 4 Surfactant & Foaming Agents, 3 Coloring Agents, 3 Rheology Modifiers, 1 API Stability Enhancers

59 Fillers, Diluents & Binders
30 Direct Compression
28 Coating Systems & Additives
26 Solubilizers
23 Controlled & Modified Release
22 Thickeners and Stabilizers
19 Lubricants & Glidants
18 Granulation
17 Parenteral
16 Topical
16 Co-Processed Excipients
11 Disintegrants & Superdisintegrants
11 Film Formers & Plasticizers
11 Taste Masking
5 Emulsifying Agents
5 Chewable & Orodispersible Aids
4 Surfactant & Foaming Agents
3 Coloring Agents
3 Rheology Modifiers
1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 39 Finished Drug Prices

3 US Medicaid Prescriptions
39 Finished Drug Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

8 APIs
6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 Others

3 EDQM
3 USP
4 Others

$ API Ref.Price (USD/KG) : 923 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Pfizer Canada Inc.

filter Patent Reset all filters

1 All

01 12409059

filter Product Reset all filters

1 All

01 1Medroxyprogesterone Acetate

filter Dosage Reset all filters

1 All

01 1Suspension

filter Exp Date Reset all filters

1 All

01 12021-04-25

Product Main Page

01

Pfizer Canada Inc.

Medroxyprogesterone Acetate

Formnext Forum

Not Confirmed

Pfizer Canada Inc.

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-04-25

Date Granted : 2006-04-18

Medroxyprogesterone Acetate

Brand Name : DEPO-PROVERA SC

Patent Number : 2409059

Filing Date : 2001-04-25

Strength per Unit : 104 mg / 0.65 mL

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Subcutaneous

Patent Expiration Date : 2021-04-25

Date Granted : 2006-04-18

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?